Skip to content
value.today

Atrium Therapeutics, Inc.

RNA
No market cap data
Compare
World rank
β€”
no current market cap
Revenue
β€”
annual
Net income
β€”
Employees
β€”

Atrium Therapeutics, Inc. in brief

Atrium Therapeutics, Inc. is a listed company in the Biotechnology industry, based in San Diego, California, USA. Its shares trade under the symbol RNA (Nasdaq).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

Atrium Therapeutics, Inc. timeline

1 events, 2025
  1. 2025
  2. β€’
    Β· approximate
    First filing with the US SEC
    The company's first electronic filing in SEC EDGAR.

Events of Atrium Therapeutics, Inc. from SEC EDGAR. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Market cap history

Not enough history yet.

Quarterly results

USD Β· three months to Β· source: SEC filings
RevenueNet income
Three months to Mar 2025: revenue $2M, net income $-7M$2MMar ’25Three months to Jun 2025: revenue $4M, net income $-13M$4MJun ’25Three months to Sep 2025: revenue $12M, net income $-0M$12MSep ’25Three months to Mar 2026: revenue $20M, net income $-17M$20MMar ’26Three months to Jun 2026: revenue $3M, net income $-20M$3MJun ’26Three months to Sep 2026: revenue $15M, net income $-4M$15MSep ’26

Latest quarter to Sep 2026: revenue $15M (+24.1% on a year earlier), net income $-4M.

Official filings of Atrium Therapeutics, Inc. with the US Securities and Exchange Commission.

Balance sheet

Total assets
$8 M
Total liabilities
$71 M
Total equity
$-63 M

As of December-2025

Top 100 institutional investors in Atrium Therapeutics, Inc.#

As of Sep 30, 2026
148 institutions held 14.0 M shares (about 65.1% of the shares outstanding) on Sep 30, 2026. The ten largest hold 32.2%. Source: SEC Form 13F filings, filed through Nov 17, 2026. Change is since the previous quarter.This quarter is still being filed: about 99% of the institutions that reported last quarter have filed so far. Institutions that have not filed yet are missing from the list, not sellers; the list is brought up to date every day.
The 25 largest institutional investors in Atrium Therapeutics, Inc.
#InstitutionShares heldChange (shares)% heldValueFiled
1Sessa Capital IM, L.P.1,500,0000 (0.00%)6.95%$12 MNov 16, 2026
2BlackRock, Inc.1,218,522-228,954 (-15.82%)5.65%$10 MNov 13, 2026
3Vanguard Capital Management LLC730,026-805 (-0.11%)3.38%$6 MNov 13, 2026
4Price T Rowe Associates Inc /MD/640,034-832,950 (-56.55%)2.97%$5 MNov 16, 2026
5O'Connor Alternative Investments, LLC559,142-37,876 (-6.34%)2.59%$5 MNov 16, 2026
6Bracebridge Capital, LLC524,477+385,238 (+276.67%)2.43%$4 MNov 16, 2026
7TIG Advisors, LLC506,926-54,607 (-9.72%)2.35%$4 MNov 16, 2026
8Bank Of America Corp /de/467,822+334,989 (+252.19%)2.17%$4 MNov 16, 2026
9Two Sigma Investments, LP427,384+81,903 (+23.71%)1.98%$4 MNov 16, 2026
10Geode Capital Management, LLC379,816-7,113 (-1.84%)1.76%$3 MNov 6, 2026
11Schonfeld Strategic Advisors LLC331,531+132,373 (+66.47%)1.54%$3 MNov 16, 2026
12Los Angeles Capital Management LLC321,486+290,009 (+921.34%)1.49%$3 MNov 12, 2026
13Arbiter Partners Capital Management LLC311,719-472,145 (-60.23%)1.45%$3 MNov 12, 2026
14Goldman Sachs Group Inc300,212-10,129 (-3.26%)1.39%$2 MNov 16, 2026
15DAFNA Capital Management LLC300,076+172,076 (+134.43%)1.39%$2 MNov 16, 2026
16State Street Corp291,023+19,261 (+7.09%)1.35%$2 MNov 12, 2026
17ADAR1 Capital Management, LLC267,586+209,898 (+363.85%)1.24%$2 MNov 16, 2026
18Citadel Advisors LLC218,447+150,808 (+222.96%)1.01%$2 MNov 16, 2026
19BlueCrest Capital Management Ltd200,000+100,000 (+100.00%)0.93%$2 MNov 13, 2026
20Quantinno Capital Management LP178,818+151,400 (+552.19%)0.83%$1 MNov 13, 2026
21Yakira Capital Management, Inc.178,316+45,269 (+34.02%)0.83%$1 MNov 13, 2026
22Polar Asset Management Partners Inc.163,200+13,200 (+8.80%)0.76%$1 MNov 16, 2026
23Nexpoint Asset Management, L.P.150,0250 (0.00%)0.70%$1 MNov 16, 2026
24AWM Investment Company, Inc.150,000+42,500 (+39.53%)0.70%$1 MNov 13, 2026
25Millennium Management LLC147,661-52,898 (-26.38%)0.68%$1 MNov 16, 2026
Show all 100: investors 26 to 100
Institutional investors 26 to 100 in Atrium Therapeutics, Inc.
#InstitutionShares heldChange (shares)% heldValueFiled
26Tudor Investment Corp Et Al140,874+11,283 (+8.71%)0.65%$1 MNov 16, 2026
27Nomura Holdings Inc137,417+23 (+0.02%)0.64%$1 MNov 16, 2026
28Charles Schwab Investment Management Inc137,045+6,828 (+5.24%)0.64%$1 MNov 16, 2026
29Northern Trust Corp118,584-1,197 (-1.00%)0.55%$1 MNov 16, 2026
30Groupe la Francaise116,273+36,000 (+44.85%)0.54%$1 MNov 12, 2026
31Credit Industriel Et Commercial113,723+24,000 (+26.75%)0.53%$1 MNov 13, 2026
32Kalehua Capital Management LLC112,652New0.52%$1 MNov 13, 2026
33Squarepoint Ops LLC112,535-34,208 (-23.31%)0.52%$1 MNov 9, 2026
34Cantor Fitzgerald, L. P.111,331-402,503 (-78.33%)0.52%$1 MNov 16, 2026
35Vanguard Fiduciary Trust Co110,241+280 (+0.25%)0.51%$1 MNov 13, 2026
36Athos Capital Ltd107,9650 (0.00%)0.50%$1 MNov 13, 2026
37Qube Research & Technologies Ltd106,532New0.49%$1 MNov 13, 2026
38Marble Bar Asset Management LLP103,898+49 (+0.05%)0.48%$1 MNov 16, 2026
39Vanguard Portfolio Management LLC102,955+1,760 (+1.74%)0.48%$1 MNov 13, 2026
40Balyasny Asset Management L.P.102,041-3,834 (-3.62%)0.47%$1 MNov 16, 2026
41Adage Capital Partners GP, L.L.C.100,0000 (0.00%)0.46%$1 MNov 16, 2026
42Morgan Stanley80,112+38,170 (+91.01%)0.37%$1 MNov 13, 2026
43Acadian Asset Management LLC78,834New0.37%$1 MNov 9, 2026
44Jacobs Levy Equity Management, Inc67,565+13,573 (+25.14%)0.31%$1 MNov 16, 2026
45Jane Street Group, LLC63,752-46,058 (-41.94%)0.30%$1 MNov 12, 2026
46ExodusPoint Capital Management, LP62,227-55,048 (-46.94%)0.29%$1 MNov 16, 2026
47Kennedy Capital Management LLC61,255+26,276 (+75.12%)0.28%$1 MNov 13, 2026
48Prelude Capital Management, LLC60,438New0.28%$1 MNov 16, 2026
49Marshall Wace, LLP59,327New0.28%$0 MNov 13, 2026
50Trium Capital LLP58,382-54,896 (-48.46%)0.27%$0 MOct 16, 2026
51FMR LLC55,892+22,360 (+66.68%)0.26%$0 MNov 10, 2026
52Mercer Global Advisors Inc /adv48,150New0.22%$0 MNov 16, 2026
53Prudential Financial Inc46,526New0.22%$0 MNov 16, 2026
54Oddo BHF Asset Management Sas45,0900 (0.00%)0.21%$0 MNov 16, 2026
55Caxton Associates LLP44,2300 (0.00%)0.20%$0 MNov 13, 2026
56Alethea Capital Management, LLC43,7580 (0.00%)0.20%$0 MNov 13, 2026
57Algert Global LLC40,180New0.19%$0 MNov 17, 2026
58Slotnik Capital, LLC39,930-197,707 (-83.20%)0.19%$0 MNov 16, 2026
59Bank of New York Mellon Corp38,324-928 (-2.36%)0.18%$0 MNov 5, 2026
60XTX Topco Ltd37,422New0.17%$0 MNov 16, 2026
61Gabelli Funds LLC36,312New0.17%$0 MNov 12, 2026
62Jump Financial, LLC33,676+2,659 (+8.57%)0.16%$0 MNov 13, 2026
63LMR Partners LLP32,5000 (0.00%)0.15%$0 MNov 16, 2026
64Nuveen, LLC31,098+27 (+0.09%)0.14%$0 MNov 10, 2026
65AQR Capital Management LLC30,976-141,259 (-82.02%)0.14%$0 MNov 16, 2026
66GABELLI & Co INVESTMENT ADVISERS, INC.30,700New0.14%$0 MNov 12, 2026
67Point72 Asset Management, L.P.28,917New0.13%$0 MNov 16, 2026
68Weiss Asset Management LP28,237-191,493 (-87.15%)0.13%$0 MNov 16, 2026
69UBS Group AG26,483+6,911 (+35.31%)0.12%$0 MNov 10, 2026
70Renaissance Technologies LLC23,700+8,729 (+58.31%)0.11%$0 MNov 12, 2026
71AlphaCentric Advisors LLC22,301+8,823 (+65.46%)0.10%$0 MNov 3, 2026
72Landscape Capital Management, L.L.C.20,158New0.09%$0 MNov 10, 2026
73Fortress Investment Group LLC20,000New0.09%$0 MNov 16, 2026
74Bridgeway Capital Management, LLC19,729New0.09%$0 MNov 16, 2026
75Empowered Funds, LLC19,729New0.09%$0 MNov 13, 2026
76Russell Investments Group, Ltd.19,235+14,760 (+329.83%)0.09%$0 MNov 6, 2026
77Rhumbline Advisers17,111+532 (+3.21%)0.08%$0 MNov 10, 2026
78Alliancebernstein L.P.17,1100 (0.00%)0.08%$0 MNov 16, 2026
79Bluefin Capital Management, LLC16,0110 (0.00%)0.07%$0 MNov 16, 2026
80Axq Capital, LP15,885+4,508 (+39.62%)0.07%$0 MNov 12, 2026
81Caption Management, LLC15,145-60,132 (-79.88%)0.07%$0 MNov 16, 2026
82Invesco Ltd.14,692+518 (+3.65%)0.07%$0 MNov 12, 2026
83Janus Henderson Group Ltd.13,833β€”0.06%$0 MNov 16, 2026
84Spark Investment Management LLC13,300New0.06%$0 MNov 13, 2026
85Deutsche Bank AG\13,226-1,741 (-11.63%)0.06%$0 MNov 6, 2026
86Kestra Private Wealth Services, LLC12,080+1,710 (+16.49%)0.06%$0 MNov 6, 2026
87HRT Financial LP11,711New0.05%$0 MNov 13, 2026
88Wealth Enhancement Advisory Services, LLC11,709New0.05%$0 MOct 13, 2026
89Virtu Financial LLC11,280New0.05%$0 MNov 17, 2026
90Jpmorgan Chase & Co11,050+1,662 (+17.70%)0.05%$0 MNov 12, 2026
91Centiva Capital, LP10,346New0.05%$0 MNov 13, 2026
92BNP Paribas Financial Markets9,406+1,505 (+19.05%)0.04%$0 MNov 12, 2026
93Wells Fargo & Company/mn9,033-8,418 (-48.24%)0.04%$0 MNov 16, 2026
94MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.6,948+346 (+5.24%)0.03%$0 MNov 16, 2026
95Tower Research Capital LLC (TRC)6,393+4,677 (+272.55%)0.03%$0 MNov 16, 2026
96Barclays PLC5,856+3,157 (+116.97%)0.03%$0 MNov 6, 2026
97Vanguard Global Advisers, LLC5,582-3 (-0.05%)0.03%$0 MNov 13, 2026
98Walleye Capital LLC4,618New0.02%$0 MNov 13, 2026
99Skandinaviska Enskilda Banken AB (publ)4,4000 (0.00%)0.02%$0 MNov 12, 2026
100Strs Ohio3,700+1,100 (+42.31%)0.02%$0 MOct 30, 2026

All 148 institutional investors, with who bought and sold β†’

Mutual funds holding Atrium Therapeutics, Inc.#

130 funds hold shares worth $47 M (about 16.3% of the company). Since their previous reports 61 added shares and 56 sold, selling $5 M net.
Mutual funds holding Atrium Therapeutics, Inc.
FundSharesValueOf the companyOf the fundChange in sharesReport
πŸ‡ΊπŸ‡Έ T. Rowe Price Health Sciences Fund, Inc.T. Rowe Price Associates, Inc.566,428$8 M2.6%0.06%βˆ’15%Jun 30, 2026
πŸ‡ΊπŸ‡Έ Vanguard Total Stock Market Index FundThe Vanguard Group, Inc.518,416$7 M2.4%<0.01%+17%Jun 30, 2026
πŸ‡ΊπŸ‡Έ T. Rowe Price New Horizons Fund, Inc.T. Rowe Price Associates, Inc.443,263$6 M2.1%0.04%βˆ’0.0%Jun 30, 2026
πŸ‡ΊπŸ‡Έ iShares Russell 2000 ETFBlackRock Fund Advisors377,354$5 M1.7%<0.01%+26%Jun 30, 2026
πŸ‡ΊπŸ‡Έ Vanguard Extended Market Index FundThe Vanguard Group, Inc.188,626$3 M0.87%<0.01%+18%Jun 30, 2026
πŸ‡ΊπŸ‡Έ BlackRock Event Driven Equity FundBlackRock Advisors, LLC175,388$2 M0.81%0.05%βˆ’0.0%May 29, 2026
πŸ‡ΊπŸ‡Έ Nexpoint Merger Arbitrage FundNexPoint Asset Management, L.P.135,138$2 M0.63%0.12%no changeJun 30, 2026
πŸ‡ΊπŸ‡Έ Fidelity Small Cap Index FundFidelity Management & Research Company LLC154,179$2 M0.71%<0.01%+29%Jul 31, 2026
πŸ‡ΊπŸ‡Έ iShares Russell 2000 Growth ETFBlackRock Fund Advisors88,107$1 M0.41%<0.01%+0.6%Jun 30, 2026
πŸ‡ΊπŸ‡Έ Fidelity Extended Market Index FundFidelity Management & Research Company LLC73,533$1 M0.34%<0.01%βˆ’0.8%May 31, 2026
πŸ‡ΊπŸ‡Έ Schwab U.S. Small-Cap ETFCharles Schwab Investment Management, Inc.67,639$1 M0.31%<0.01%βˆ’1.5%May 31, 2026
πŸ‡ΊπŸ‡Έ Vanguard Russell 2000 Index FundThe Vanguard Group, Inc.62,889$1 M0.29%<0.01%+9.7%May 31, 2026
πŸ‡ΊπŸ‡Έ iShares Micro-Cap ETFBlackRock Fund Advisors48,184$1 M0.22%0.04%newJun 30, 2026
πŸ‡ΊπŸ‡Έ T. Rowe Price Health Sciences PortfolioT. Rowe Price Associates, Inc.41,700$1 M0.19%0.07%no changeJun 30, 2026
πŸ‡ΊπŸ‡Έ iShares Russell 2000 Value ETFBlackRock Fund Advisors41,090$1 M0.19%<0.01%+400%Jun 30, 2026
πŸ‡ΊπŸ‡Έ Schwab Small-Cap Index FundCharles Schwab Investment Management, Inc.35,118$0 M0.16%<0.01%+32%Jul 31, 2026
πŸ‡ΊπŸ‡Έ Master Small Cap Index SeriesBlackRock Advisors, LLC28,368$0 M0.13%<0.01%+47%Jun 30, 2026
πŸ‡ΊπŸ‡Έ Fidelity Total Market Index FundFidelity Management & Research Company LLC26,529$0 M0.12%<0.01%no changeMay 31, 2026
πŸ‡ΊπŸ‡Έ Fidelity Series Total Market Index FundFidelity Management & Research Company LLC21,240$0 M0.10%<0.01%+1.5%May 31, 2026
πŸ‡ΊπŸ‡Έ iShares Core S&P Total U.S. Stock Market ETFBlackRock Fund Advisors18,530$0 M0.09%<0.01%+3.0%Jun 30, 2026
πŸ‡ΊπŸ‡Έ EQ/2000 Managed Volatility PortfolioEquitable Investment Management Group, LLC17,781$0 M0.08%<0.01%+42%Jun 30, 2026
πŸ‡ΊπŸ‡Έ Nuveen Small Cap Blend Index FundTeachers Advisors, LLC19,864$0 M0.09%<0.01%+41%Jul 31, 2026
πŸ‡ΊπŸ‡Έ Putnam Dynamic Asset Allocation Growth FundFranklin Advisers, Inc.14,908$0 M0.07%<0.01%+7244%Jun 30, 2026
πŸ‡ΊπŸ‡Έ Health Sciences TrustJohn Hancock Variable Trust Advisers LLC14,900$0 M0.07%0.08%no changeJun 30, 2026
πŸ‡ΊπŸ‡Έ Fidelity SAI Merger Arbitrage FundFidelity Diversifying Solutions LLC15,000$0 M0.07%0.03%no changeJul 31, 2026
πŸ‡ΊπŸ‡Έ BlackRock Advantage Small Cap Core FundBlackRock Advisors, LLC12,237$0 M0.06%<0.01%+2.8%May 29, 2026
πŸ‡ΊπŸ‡Έ Fidelity Enhanced Small Cap Core ETFFidelity Management & Research Company LLC11,112$0 M0.05%<0.01%+11%Jun 30, 2026
πŸ‡ΊπŸ‡Έ EQ/T.Rowe Price Health Sciences PortfolioEquitable Investment Management Group, LLC10,400$0 M0.05%0.08%no changeJun 30, 2026
πŸ‡ΊπŸ‡Έ Putnam Dynamic Asset Allocation Balanced FundFranklin Advisers, Inc.10,176$0 M0.05%<0.01%+7117%Jun 30, 2026
πŸ‡ΊπŸ‡Έ Vanguard Russell 2000 Growth Index FundThe Vanguard Group, Inc.10,524$0 M0.05%<0.01%+8.0%May 31, 2026
πŸ‡ΊπŸ‡Έ Goldman Sachs Absolute Return Tracker FundGoldman Sachs Asset Management, L.P.10,078$0 M0.05%<0.01%+3271%Jun 30, 2026
πŸ‡ΊπŸ‡Έ Ultra-Small Company Market FundBridgeway Capital Management, LLC10,000$0 M0.05%0.09%newJun 30, 2026
πŸ‡ΊπŸ‡Έ Fidelity Small Cap Growth Index FundFidelity Management & Research Company LLC9,178$0 M0.04%<0.01%+7.8%Jun 30, 2026
πŸ‡ΊπŸ‡Έ Fidelity Nasdaq Composite Index FundFidelity Management & Research Company LLC8,998$0 M0.04%<0.01%no changeMay 31, 2026
πŸ‡ΊπŸ‡Έ EQ/Small Company Index PortfolioEquitable Investment Management Group, LLC8,380$0 M0.04%<0.01%+33%Jun 30, 2026
πŸ‡ΊπŸ‡Έ Vanguard Balanced Index FundThe Vanguard Group, Inc.8,159$0 M0.04%<0.01%+2.4%Jun 30, 2026
πŸ‡ΊπŸ‡Έ Nuveen Equity Index FundTeachers Advisors, LLC9,612$0 M0.04%<0.01%no changeJul 31, 2026
πŸ‡ΊπŸ‡Έ Multi-Manager Small Cap Equity Strategies FundColumbia Funds Series Trust I8,322$0 M0.04%<0.01%newMay 31, 2026
πŸ‡ΊπŸ‡Έ Schwab U.S. Broad Market ETFCharles Schwab Investment Management, Inc.8,226$0 M0.04%<0.01%no changeMay 31, 2026
πŸ‡ΊπŸ‡Έ LVIP State Street Small-Cap Index FundLincoln Financial Investments Corporation7,850$0 M0.04%<0.01%no changeJun 30, 2026
πŸ‡ΊπŸ‡Έ Small Cap Index FundNorthern Trust Investments, Inc.7,436$0 M0.03%<0.01%+12%Jun 30, 2026
πŸ‡ΊπŸ‡Έ Vanguard Total World Stock Index FundThe Vanguard Group, Inc.8,760$0 M0.04%<0.01%no changeJul 31, 2026
πŸ‡ΊπŸ‡Έ Goldman Sachs Small Cap Growth Insights FundGoldman Sachs Asset Management, L.P.8,636$0 M0.04%0.03%βˆ’59%Jul 31, 2026
πŸ‡ΊπŸ‡Έ Fidelity ZERO Total Market Index FundFidelity Management & Research Company LLC8,249$0 M0.04%<0.01%+15%Jul 31, 2026
πŸ‡ΊπŸ‡Έ Vanguard Institutional Total Stock Market Index FundThe Vanguard Group, Inc.6,870$0 M0.03%<0.01%no changeJun 30, 2026
πŸ‡ΊπŸ‡Έ EQ/AB Small Cap Growth PortfolioEquitable Investment Management Group, LLC6,080$0 M0.03%<0.01%+52%Jun 30, 2026
πŸ‡ΊπŸ‡Έ Schwab Total Stock Market Index FundCharles Schwab Investment Management, Inc.7,037$0 M0.03%<0.01%no changeJul 31, 2026
πŸ‡ΊπŸ‡Έ Fidelity Small Cap Value Index FundFidelity Management & Research Company LLC5,870$0 M0.03%<0.01%+491%Jun 30, 2026
πŸ‡ΊπŸ‡Έ Global X Russell 2000 ETFGlobal X Management Company LLC6,837$0 M0.03%<0.01%+33%Jul 31, 2026
πŸ‡ΊπŸ‡Έ MetLife Russell 2000 Index PortfolioBrighthouse Investment Advisers, LLC5,194$0 M0.02%<0.01%+38%Jun 30, 2026
πŸ‡ΊπŸ‡Έ Fidelity ZERO Extended Market Index FundFidelity Management & Research Company LLC6,145$0 M0.03%<0.01%+19%Jul 31, 2026
πŸ‡ΊπŸ‡Έ The Gabelli ABC FundGabelli Funds, LLC5,000$0 M0.02%0.02%no changeJun 30, 2026
πŸ‡ΊπŸ‡Έ BlackRock Advantage Small Cap Growth FundBlackRock Funds4,913$0 M0.02%<0.01%+29%Jun 30, 2026
πŸ‡ΊπŸ‡Έ ATM Small Cap Managed Volatility PortfolioEquitable Investment Management Group, LLC4,573$0 M0.02%<0.01%+31%Jun 30, 2026
πŸ‡ΊπŸ‡Έ Small Cap Index FundThe Variable Annuity Life Insurance Company4,652$0 M0.02%<0.01%no changeMay 31, 2026
πŸ‡ΊπŸ‡Έ State Street Small/mid Cap Equity Index PortfolioSSGA Funds Management, Inc.3,870$0 M0.02%<0.01%no changeJun 30, 2026
πŸ‡ΊπŸ‡Έ Schwab 1000 Index FundCharles Schwab Investment Management, Inc.4,540$0 M0.02%<0.01%no changeJul 31, 2026
πŸ‡ΊπŸ‡Έ SIMT Small Cap FundSEI Institutional Managed Trust3,526$0 M0.02%<0.01%newJun 30, 2026
πŸ‡ΊπŸ‡Έ NVIT GS Small Cap Equity Insights FundNATIONWIDE FUND ADVISORS3,438$0 M0.02%0.02%newJun 30, 2026
πŸ‡ΊπŸ‡Έ NVIT Small Cap Index FundNATIONWIDE FUND ADVISORS3,342$0 M0.02%<0.01%+47%Jun 30, 2026
πŸ‡ΊπŸ‡Έ 1290 VT Micro Cap PortfolioEquitable Investment Management Group, LLC3,246$0 M0.02%0.02%newJun 30, 2026
πŸ‡ΊπŸ‡Έ iShares Russell 3000 ETFBlackRock Fund Advisors3,219$0 M0.01%<0.01%βˆ’0.9%Jun 30, 2026
πŸ‡ΊπŸ‡Έ Small-Cap Index PortfolioPacific Life Fund Advisors LLC3,037$0 M0.01%<0.01%+0.1%Jun 30, 2026
πŸ‡ΊπŸ‡Έ Small Cap Index TrustJohn Hancock Variable Trust Advisers LLC2,891$0 M0.01%<0.01%+27%Jun 30, 2026
πŸ‡ΊπŸ‡Έ Invesco RAFI US 1500 Small-Mid ETFInvesco Capital Management LLC2,955$0 M0.01%<0.01%βˆ’15%Jul 31, 2026
πŸ‡ΊπŸ‡Έ Vanguard Esg U.S. Stock ETFThe Vanguard Group, Inc.2,521$0 M0.01%<0.01%βˆ’0.0%May 31, 2026
πŸ‡ΊπŸ‡Έ DWS Small Cap Index VIPDWS Investment Management Americas, Inc.2,245$0 M0.01%<0.01%+37%Jun 30, 2026
πŸ‡ΊπŸ‡Έ T. Rowe Price Extended Equity Market Index FundT. Rowe Price Associates, Inc.2,227$0 M0.01%<0.01%no changeJun 30, 2026
πŸ‡ΊπŸ‡Έ Fidelity Flex Small Cap Index FundFidelity Management & Research Company LLC2,598$0 M0.01%<0.01%+23%Jul 31, 2026
πŸ‡ΊπŸ‡Έ T. Rowe Price Small-Cap Index FundT. Rowe Price Associates, Inc.2,161$0 M0.01%<0.01%+56%Jun 30, 2026
πŸ‡ΊπŸ‡Έ Diversified Equity Alpha Master PortfolioBlackRock Fund Advisors2,083$0 M<0.01%<0.01%βˆ’20%Jun 30, 2026
πŸ‡ΊπŸ‡Έ Bridge Builder Small/Mid Cap Growth FundOLIVE STREET INVESTMENT ADVISERS LLC2,049$0 M<0.01%<0.01%no changeJun 30, 2026
πŸ‡ΊπŸ‡Έ Voya RussellTM Small Cap Index PortfolioVoya Investments, LLC1,972$0 M<0.01%<0.01%+56%Jun 30, 2026
πŸ‡ΊπŸ‡Έ T. Rowe Price Total Equity Market Index FundT. Rowe Price Associates, Inc.1,886$0 M<0.01%<0.01%no changeJun 30, 2026
πŸ‡ΊπŸ‡Έ JPMorgan Small Cap Value FundJ.P. Morgan Investment Management Inc.1,788$0 M<0.01%<0.01%βˆ’5.7%Jun 30, 2026
πŸ‡ΊπŸ‡Έ Siit Extended Market Index FundSEI INVESTMENTS MANAGEMENT CORPORATION1,820$0 M<0.01%<0.01%no changeMay 31, 2026
πŸ‡ΊπŸ‡Έ Putnam Dynamic Asset Allocation Conservative FundFranklin Advisers, Inc.1,607$0 M<0.01%<0.01%+7552%Jun 30, 2026
πŸ‡ΊπŸ‡Έ iShares Russell Small/Mid-Cap Index FundBlackRock Advisors, LLC1,809$0 M<0.01%<0.01%no changeJul 31, 2026
πŸ‡ΊπŸ‡Έ EQ/Morgan Stanley Small Cap Growth PortfolioEquitable Investment Management Group, LLC1,507$0 M<0.01%<0.01%no changeJun 30, 2026
πŸ‡ΊπŸ‡Έ EQ/Common Stock Index PortfolioEquitable Investment Management Group, LLC1,450$0 M<0.01%<0.01%no changeJun 30, 2026
πŸ‡ΊπŸ‡Έ BlackRock Small Cap Index V.I. FundBlackRock Advisors, LLC1,427$0 M<0.01%<0.01%+0.1%Jun 30, 2026
πŸ‡ΊπŸ‡Έ AQR Small Cap Momentum Style FundAQR CAPITAL MANAGEMENT, LLC1,386$0 M<0.01%0.01%β€”Mar 31, 2026
πŸ‡ΊπŸ‡Έ VIP Disciplined Small Cap PortfolioFidelity Management & Research Company LLC1,290$0 M<0.01%<0.01%no changeJun 30, 2026
πŸ‡ΊπŸ‡Έ Strategic Advisers U.S. Total Stock FundStrategic Advisers LLC1,227$0 M<0.01%<0.01%βˆ’7.5%May 31, 2026
πŸ‡ΊπŸ‡Έ SA Small Cap Index PortfolioSunAmerica Asset Management, LLC1,318$0 M<0.01%<0.01%+1.9%Jul 31, 2026
πŸ‡ΊπŸ‡Έ Putnam Multi-Asset Income FundFranklin Advisers, Inc.1,092$0 M<0.01%<0.01%+8498%May 31, 2026
πŸ‡ΊπŸ‡Έ Schwab 1000 Index ETFCharles Schwab Investment Management, Inc.1,088$0 M<0.01%<0.01%no changeMay 31, 2026
πŸ‡ΊπŸ‡Έ VIP Extended Market Index PortfolioFidelity Management & Research Company LLC1,026$0 M<0.01%<0.01%+11%Jun 30, 2026
πŸ‡ΊπŸ‡Έ Putnam Dynamic Asset Allocation Equity FundFranklin Advisers, Inc.1,049$0 M<0.01%<0.01%newMay 31, 2026
πŸ‡ΊπŸ‡Έ PD Small-Cap Growth Index PortfolioPacific Life Fund Advisors LLC968$0 M<0.01%<0.01%no changeJun 30, 2026
πŸ‡ΊπŸ‡Έ CVT Russell 2000 Small Cap Index PortfolioCalvert Research and Management950$0 M<0.01%<0.01%no changeJun 30, 2026
πŸ‡ΊπŸ‡Έ Vanguard Russell 3000 Index FundThe Vanguard Group, Inc.933$0 M<0.01%<0.01%no changeMay 31, 2026
πŸ‡ΊπŸ‡Έ Venerable Small Cap Index FundVenerable Investment Advisers, LLC898$0 M<0.01%<0.01%no changeJun 30, 2026
πŸ‡ΊπŸ‡Έ AVIP BlackRock Advantage Small Cap Growth PortfolioCONSTELLATION INVESTMENTS INC808$0 M<0.01%<0.01%no changeJun 30, 2026
πŸ‡ΊπŸ‡Έ Nationwide Small Cap Index FundNATIONWIDE FUND ADVISORS946$0 M<0.01%<0.01%+0.6%Jul 31, 2026
πŸ‡ΊπŸ‡Έ SA Franklin Allocation Moderately Aggressive PortfolioSunAmerica Asset Management, LLC770$0 M<0.01%<0.01%+7600%Jun 30, 2026
πŸ‡ΊπŸ‡Έ Strategic Equity Allocation TrustJohn Hancock Variable Trust Advisers LLC766$0 M<0.01%<0.01%βˆ’20%Jun 30, 2026
πŸ‡ΊπŸ‡Έ 1290 VT Small Cap Value PortfolioEquitable Investment Management Group, LLC706$0 M<0.01%<0.01%+412%Jun 30, 2026
πŸ‡ΊπŸ‡Έ Vanguard Russell 2000 Value Index FundThe Vanguard Group, Inc.724$0 M<0.01%<0.01%+5.8%May 31, 2026
πŸ‡ΊπŸ‡Έ iShares Total U.S. Stock Market Index FundBlackRock Advisors, LLC767$0 M<0.01%<0.01%no changeJul 31, 2026

Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses Β· as of Jul 31, 2026. The 100 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.

Insider trading at Atrium Therapeutics, Inc.#

Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.

Bought, 12 months
$0
0 purchases, 0 insiders
Sold, 12 months
$0
0 sales, 0 insiders
Net, 12 months
$0
open market only
Insiders on file
8
since
Atrium Therapeutics, Inc.: latest insider trades
TradedInsiderTradeSharesPriceValueOwned afterFiling
filed W. Michael FlanaganDirectorShares withheld for tax-22,812$8.950$204 K31,974Form 4
filed Husam YounisChief Scientific OfficerShares withheld for tax-11,216$8.950$100 K41,441Form 4
filed Kathleen P. GallagherSee Remarks, DirectorShares withheld for tax-11,632$8.950$104 K119,729Form 4
filed Sarah BoyceDirectorShares withheld for tax-126,418$8.950$1.1 M138,668Form 4
filed Rocio Martin HoyosChief Strategy OfficerShares withheld for tax-8,320$8.950$74 K38,340Form 4
filed Brendan R. WinslowChief Financial OfficerShares withheld for tax-6,742$8.950$60 K36,859Form 4
filed Stephanie KenneySee RemarksShares withheld for tax-2,375$8.950$21 K33,085Form 4
filed Steven George HughesChief Medical OfficerShares withheld for tax-21,459$8.950$192 K51,638Form 4

Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals

Atrium Therapeutics, Inc. scorecard#

Passes 0 of the 1 checks that could be worked out. Fiscal year 2025.

  • Valuationnot known
    • –P/E below its peers' medianNo market cap.
    • –Price to book below its peers' medianNo market cap.
    • –Price to sales below its peers' medianNo market cap.
    • –Free cash flow yield above 5%No market cap.
    • –Earnings yield above the 10-year Treasury yieldNo market cap.
    • –The price assumes slower growth than the last three years'No market cap.
  • Growthnot known
    • –Revenue grew in the newest yearRevenue of the year before is not on file.
    • –Revenue up more than 5% a year over three yearsRevenue of three years earlier is not on file.
    • –Faster growth over three years than its peers' medianRevenue of three years earlier is not on file.
    • –Earnings per share grew in the newest yearEarnings per share of two years are not on file.
    • –Net income higher than five years earlierNet income of five years earlier is not on file.
    • –Revenue rose in at least four of the last five yearsFive years of revenue changes are not on file.
  • Profitabilitynot known
    • –Profitable in the newest yearNo net income on file.
    • –Profitable in each of the last five yearsFive years of net income are not on file.
    • –Operating margin above its peers' medianNo operating margin on file.
    • –Return on equity above 15%No return on equity (equity missing or negative).
    • –Return on invested capital above 10%No return on invested capital on file.
    • –Operating margin wider than three years earlierOperating margins of three years earlier are not on file.
  • Financial health0 of 1
    • βœ—Short-term assets cover short-term liabilities0.1Γ—Current ratio 0.07 at the end of fiscal 2025.
    • –Debt below equityDebt or equity is not on file (or equity is negative).
    • –Net debt below three years of EBITDANet debt to EBITDA is not on file.
    • –Operating income covers interest five timesInterest expense is not on file.
    • –Cash from operations positive in each of the last three yearsThree years of operating cash flow are not on file.
    • –Altman Z-score outside the distress zoneThe Z-score's figures are not all on file.
  • Shareholder returnsnot known
    • –Pays a dividendDividends are not on file.
    • –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
    • –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
    • –Share count up no more than 2% in a yearShare counts of two years are not on file.
    • –Dividends and buybacks above 3% of the market valueNo market cap.
    • –Free cash flow covers dividends and buybacksCash from operations or capital spending is not on file.

Worked out from the statements as filed (sec), the medians of Biotechnology, the 10-year Treasury yield of Nov 13, 2026 and the market cap (too old for the valuation checks, which need one at most 60 days old). A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work

Events at Atrium Therapeutics, Inc.#

What the company reported to the SEC within four business days (Form 8-K), newest first.

No warning signs in the last three years: no bankruptcy, delisting notice, withdrawn financial statements, auditor change, cybersecurity incident, debt called early or impairment was reported.

Change in control 1 Β· Directors and officers 1 Β· Material agreement 2 Β· Unregistered share sale 1 Β· Results announced 3

Atrium Therapeutics, Inc.: events reported to the SEC
FiledWhat happenedFiling
Results announced8-K
Material agreementUnregistered share sale8-K
Results announced8-K
Results announced8-K
Change in controlDirectors and officersMaterial agreement8-K

Source: SEC EDGAR, Form 8-K item numbers Β· as of Nov 12, 2026

Lobbying by Atrium Therapeutics, Inc.#

$190 K spent on lobbying the US Congress and federal agencies in 2026, most often on health issues.

Lobbying, 2026
$190 K
#909 among companies on value.today
Own lobbyists
No
only outside firms
Firms hired
1
in 2026
2026 so far
$190 K
  • Health Issues3 reports

Lobbying firms hired in 2026

FEROX STRATEGIES $190 K

Atrium Therapeutics, Inc.: lobbying spending by year
YearSpendingOwn lobbyistsReports
2026 (so far)$190 Kβ€”3

Source: Lobbying Disclosure Act reports (Form LD-2). Filed as β€œAtrium Therapeutics”. Reports round to the nearest $10,000, and one of less than $5,000 counts as zero

Peer comparison Β· Biotechnology

CompanyMarket capP/ENet marginRev. growth
Atrium Therapeutics, Inc.πŸ‡ΊπŸ‡Έβ€”β€”β€”β€”
Novo Nordisk A/SπŸ‡©πŸ‡°$203.2 B13.1Γ—33.1%+10.8%
Vertex Pharmaceuticals IncorporatedπŸ‡ΊπŸ‡Έ$134.3 B33.8Γ—30.7%+8.9%
Moderna, Inc.πŸ‡ΊπŸ‡Έ$90.1 Bβ€”-110.5%-39.9%
Regeneron Pharmaceuticals, Inc.πŸ‡ΊπŸ‡Έ$84.1 B17.5Γ—28.5%+1.0%
Argenx SEπŸ‡³πŸ‡±$52.8 B40.9Γ—31.1%+89.9%
CSL LimitedπŸ‡¦πŸ‡Ί$51.6 Bβ€”-16.4%β€”
Samsung Biologics Co., Ltd.πŸ‡°πŸ‡·$51.5 B40.5Γ—39.2%β€”
UCB SAπŸ‡§πŸ‡ͺ$48.6 B26.3Γ—20.1%+31.1%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Balance sheet:
As of December-2025
Profile updated:
Nov 5, 2026

Figures from value.today research, SEC filing; financial statements from SEC filings.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Atrium Therapeutics, Inc.? Verify and update this profile β€” free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Atrium Therapeutics, Inc.'s ranking on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Atrium Therapeutics, Inc.? Suggest a correction